Risk Factors for Medium-term Adverse Outcomes and Predictive Modeling for Breast Cancer Patients

Sponsor
Hospital Galdakao-Usansolo (Other)
Overall Status
Completed
CT.gov ID
NCT02439554
Collaborator
(none)
1,463
1
50
29.3

Study Details

Study Description

Brief Summary

This subproject is included in a project coordinated between program groups Evaluation of Health Services of Epidemiology and Public Health (Project CAMISS). The overall objective is to evaluate different aspects of health care received by patients with breast cancer from the diagnostic process, treatment, complications, survival and quality of life, to provide information to improve the effectiveness of interventions, reduce variability, have best predictive rules and increase the quality of life. The main objective of the subproject is to create and validate prospectively predictive rules of recurrence, complications, mortality, changes in quality of life in these patients at admission and one/two years of treatment and to evaluate the external validity of our rules to predict relapses, complications and mortality in the retrospective sample of patients participating in screening programs. Observational methodology with information available from a retrospective cohort of women diagnosed between 2000 and 2009 and another 2-year prospective follow-up included 2040 incident cases of breast cancer in 18 hospitals of 5 regions. Cohorts will learn clinical and health care diagnosis, tumor, treatment, hospital, follow-up (complications, relapse, and vital status) cost and quality of life. Prediction rules are created by means of regression/Cox models at the prospective sample and also investigators will assess the external validity in the retrospective cohort in the case of recurrence, complications and mortality. Expected results: There are currently no results of cohort analysis of the diagnostic process of care that integrates different aspects. The study will create tools to assist prognostic and therapeutic decision making process in these patients

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    1463 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Risk Factors for Medium-term Adverse Outcomes and Predictive Modeling for Breast Cancer Patients
    Actual Study Start Date :
    Apr 1, 2013
    Actual Primary Completion Date :
    Jun 1, 2017
    Actual Study Completion Date :
    Jun 1, 2017

    Outcome Measures

    Primary Outcome Measures

    1. Change in quality of life questionnaire module for breast cancer patients [Change from baseline in quality of life at 2 years]

    Secondary Outcome Measures

    1. Mortality data [Mortality at 2 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Women over the age of 18 with both incidental in situ and infiltrating breast cancer.
    Exclusion Criteria:
    • Lymphoma, sarcoma, lobular carcinoma in situ and inflammatory carcinoma of the breast are excluded

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hospital Galdakao-Usansolo Galdakao Bizkaia Spain 48960

    Sponsors and Collaborators

    • Hospital Galdakao-Usansolo

    Investigators

    • Principal Investigator: Susana GArcía, PhD, MD, Hospital Galdakao-Usansolo

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Susana García Gutiérrez, PhD, Md, Hospital Galdakao-Usansolo
    ClinicalTrials.gov Identifier:
    NCT02439554
    Other Study ID Numbers:
    • PI12/01842
    First Posted:
    May 8, 2015
    Last Update Posted:
    Mar 26, 2019
    Last Verified:
    Mar 1, 2019
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 26, 2019